Literature DB >> 7743657

Detection of anti-topoisomerase I antibodies using a full length human topoisomerase I recombinant protein purified from a baculovirus expression system.

J Whyte1, W C Earnshaw, J J Champoux, L H Parker, L Stewart, N D Hall, N J McHugh.   

Abstract

Topoisomerase I (topo I) is a major systemic sclerosis (SSc)-associated autoantigen. A cDNA construct encoding full length human topo I in a recombinant baculovirus transfer vector was used to infect insect cells in culture from which recombinant protein was purified. An ELISA using recombinant protein was evaluated in 340 sera including sera from 134 patients with SSc, of whom 33 had anti-topo I antibodies detected by immunodiffusion. A high yield of pure topo I of expected molecular mass and catalytic activity was obtained. The recombinant topo I ELISA was 92% sensitive and 98% specific in detecting anti-topo I antibodies which were present almost exclusively in patients with SSc. Therefore, the potential advantages of expressing human autoantigens in eukaryotic systems for diagnostic purposes were confirmed.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7743657      PMCID: PMC1534349          DOI: 10.1111/j.1365-2249.1995.tb03655.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  31 in total

1.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

2.  Purification and characterization of the DNA untwisting enzyme from rat liver.

Authors:  J J Champoux; B L McConaughy
Journal:  Biochemistry       Date:  1976-10-19       Impact factor: 3.162

3.  Autoantigenic epitopes on DNA topoisomerase I. Clinical and immunogenetic associations in systemic sclerosis.

Authors:  M Kuwana; J Kaburaki; T Mimori; T Tojo; M Homma
Journal:  Arthritis Rheum       Date:  1993-10

4.  Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.

Authors:  H Towbin; T Staehelin; J Gordon
Journal:  Proc Natl Acad Sci U S A       Date:  1979-09       Impact factor: 11.205

5.  Anticentromere autoantibodies. Evaluation of an ELISA using recombinant fusion protein CENP-B as antigen.

Authors:  D Vázquez-Abad; S Wallace; J L Senécal; F Joyal; A Roussin; W C Earnshaw; N Rothfield
Journal:  Arthritis Rheum       Date:  1994-02

6.  Antibody specificities of Thai and Australian scleroderma sera with topoisomerase I recombinant fusion proteins.

Authors:  D S Cram; N Fisicaro; L J McNeilage; R L Coppel; L C Harrison
Journal:  J Immunol       Date:  1993-12-15       Impact factor: 5.422

7.  3 cases of anti-Scl-70 (topoisomerase I) antibody associated with central nervous system lupus without renal disorder.

Authors:  M Mukai; A Sagawa; T Atsumi; S Jodo; Y Amasaki; T Nakabayashi; I Watanabe; A Fujisaku; S Nakagawa
Journal:  J Rheumatol       Date:  1993-09       Impact factor: 4.666

8.  Identification of a universal B cell epitope on DNA topoisomerase I, an autoantigen associated with scleroderma.

Authors:  T Kato; K Yamamoto; H Takeuchi; M Okubo; E Hara; S Nakada; K Oda; K Ito; K Nishioka
Journal:  Arthritis Rheum       Date:  1993-11

9.  Anti-topoisomerase I antibodies in silica-associated systemic sclerosis. A model for autoimmunity.

Authors:  N J McHugh; J Whyte; G Harvey; U F Haustein
Journal:  Arthritis Rheum       Date:  1994-08

10.  A recombinant topoisomerase I ELISA: screening for IgG, IgM and IgA anti-topo I autoantibodies in human sera.

Authors:  R Verheijen; B A de Jong; W J van Venrooij
Journal:  Clin Exp Immunol       Date:  1992-09       Impact factor: 4.330

View more
  2 in total

1.  IgM, IgG, and IgA anti-DNA topoisomerase I antibodies in systemic sclerosis.

Authors:  Erasmo Martínez-Cordero; Alejandro Padilla Trejo; Diana E Aguilar León
Journal:  J Clin Lab Anal       Date:  2009       Impact factor: 2.352

2.  Relationship between natural and infection-induced antibodies in systemic autoimmune diseases (SAD): SLE, SSc and RA.

Authors:  K Böröcz; D Simon; S Erdő-Bonyár; K T Kovács; É Tuba; L Czirják; P Németh; T Berki
Journal:  Clin Exp Immunol       Date:  2020-10-13       Impact factor: 4.330

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.